FDA approves 2 gene therapies for sickle cell. One is the first to use the editing tool CRISPR
← Back to stories
National80 articles from 48 sources across the spectrum· Updated 1025d ago
30 across the spectrum · tap a section to jump
How each side is putting it
Left
9 viewpointsRan by 4 outlets across the spectrum· Quartz, Minneapolis Star Tribune
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person
Ran by 3 outlets across the spectrum· NPR, Wyoming Public Media
Center
20 viewpointsFDA approves groundbreaking CRISPR-based gene therapies for sickle cell disease
Ran by 4 outlets across the spectrum· WTOP Washington DC, WDIO Duluth
Ran by 2 outlets· NBC Chicago, NBC Los Angeles
Ran by 4 outlets· ABC 13 Houston, ABC 7 New York, +2 more
Ran by 13 outlets· KTVB Boise, WUSA9, +11 more
Right
1 viewpointTwo new cutting-edge sickle cell treatments approved by FDA despite side effects
Two gene therapies for sickle cell disease approved in US
FDA approves world's first CRISPR gene-editing drug for sickle-cell disease
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
3 articlesCRISPR-based gene editing therapy approved by the FDA for the first time
Center
0 articlesNone
Right
0 articlesNone